Abstract
Cancer is the leading cause of death worldwide. Chemotherapy and radiotherapy have been used to treat cancer; however, these methods have serious side effects. Nanomedicine has emerged as a hope for cancer patients in the recent past. Various nanomedical carriers such as liposomal nanoparticles, polymeric nanoparticles, etc. have been developed to carry anticancer drugs to target site. Among these, polymeric nanoparticles have been used extensively due to their unique properties. Of various natural and synthetic polymers, chitosan is most suitable as a carrier of anticancer drugs. It is a natural polymer obtained from deacetylation of chitin. Researchers have worked on the anticancer drug encapsulation in chitosan nanoparticles and its targeted drug delivery. Chitosan nanoparticles are safe and biodegradable and can release drugs at controlled rates to the target site. Chitosan nanoparticles can be synthesized by various methods such as ionic gelation method, emulsion polymerization method, etc. Although research is going on worldwide, more research is needed in the area of anticancer drug encapsulation in chitosan nanoparticles and its delivery to target sites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexis F, Pridgen EM, Langer R, Farokhzad OC (2010) Nanoparticle technologies for cancer therapy. In: Schäfer-Korting M (ed) Drug delivery. Springer, Berlin/Heidelberg, pp 55–86
Amidi M, Mastrobattista E, Jiskoot W, Hennink WE (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62:59–82
Anitha A, Deepagan VG, Divya Rani VV, Menon D, Nair SV, Jayakumar R (2011) Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym 84:1158–1164
Anitha A, Chennazhi KP, Nair SV, Jayakumar R (2012) 5-Flourouracil loaded N,O –carboxymethyl CSNPs as an anticancer nanomedicine for breast cancer. J Biomed Nanotechnol 8:1–14
Anitha A, Uthaman S, Nair SV, Jayakumar R, Lakshmanan VK (2013) Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer. J Biomed Nanotechnol 9:335–340
Baraton MI, Chen X, Gonsalves KE (1996) Application of fourier transform infrared spectroscopy to nanostructured materials surface characterization. ACS Symp Ser 622:312–333
Berthold A, Cremer K, Kreuter J (1996) Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release 39:17–25
Bhui DK, Bar H, Sarkar P, Sahoo GP et al (2009) Synthesis and UV-vis spectroscopic study of silver nanoparticles in aqueous SDS solution. J Mol Liq 145:33–37
Bodnar M, Hartmann J, Borbely J (2005) Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6:2521–2527
Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125–132
Chaudhury A, Das S (2011) Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS Pharm Sci Tech 12:10–20
Cheng M, Han J, Li Q, He B, Zha B et al (2012) Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies. J Biomed Mater Res Part B Appl Biomater 100:2035–2043
Creighton JA, Eadon DG (1991) Ultraviolet-visible absorption spectra of the colloidal metallic elements. J Chem Soc Faraday Trans 87:3881–3891
De Rosa G, Caraglia M, Salmaso S, Elbayoumi T (2013) Nanotechnologies in Cancer. J Drug Deliv. https://doi.org/10.1155/2013/604293
Debnath S, Datta D, Babu MN et al (2010) Studies on the preparation and evaluation of chitosan nanoparticles containing cytarabine. Int J Pharm Sci Nanotechnol 3:957–964
Derakhshandeh K, Fathi S (2012) Role of chitosan nanoparticles in the oral absorption of Gemcitabine. Int J Pharm 437:172–177
Duan J, Zhang Y, Han S, Chen Y, Li B et al (2010) Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 400:211–220
Duan J, Liu M, Zhang Y, Zhao J, Pan Y, Yang X (2012) Folate-decorated chitosan/doxorubicin poly(butyl)cyanoacrylate nanoparticles for tumor-targeted drug delivery. J Nanopart Res 14:761. https://doi.org/10.1007/s11051-012-0761-4
El-Shabouri M (2002) Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 249:101–108
Eppler AS, Rupprechter G, Anderson EA, Somorjai GA (2000) Thermal and chemical stability and adhesion strength of Pt nanoparticle arrays supported on silica studied by transmission electron microscopy and atomic force microscopy. J Phys Chem B 104:7286–7292
Feng C, Wang Z, Jiang C, Kong M, Zhou X et al (2013) Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Int J Pharm 457:158–167
Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577–5591
Goldberg M, Langer R, Jia X (2007) Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 18:241–268
Guo Y, Chu M, Tan S, Zhao S, Liu H et al (2014) Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm 11:59–70
Hao E, Schatz GC, Hupp JT (2004) Synthesis and optical properties of anisotropic metal nanoparticles. J Fluoresc 14:331–341
Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN (2012) Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine 7:1851–1863
Huang P, Yang C, Liu J, Wang W, Guo S et al (2014) Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone grafted hyaluronic acid nanoparticles. J Mater Chem 2:4021–4033
Hwang HY, Kimb IS, Kwon IC, Kim YH (2008) Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 128:23–31
Jain A, Jain SK, Ganesh N, Barve J, Beg AM (2010) Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. J Nanotechonol 6:179–190
Jari V, Rose M, Heikki K, Marjaana R, Eija S, Raija A (2004) Chitosan-coated paper: Effects of nisin and different acids on the antimicrobial activity. J Appl Polym Sci 94:986–993
Jeong YI, Jin SG, Kim IY, Pei J, Wen M et al (2010) Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surf B 79:149–155
Ji J, Wu D, Liu L, Chen J, Xu Y (2012a) Preparation, evaluation, and in vitro release of folic acid conjugated O-Carboxymethyl chitosan nanoparticles loaded with methotrexate. J Appl Polym Sci 125:E208–E215
Ji J, Wu D, Liu L, Chen J, Xu Y (2012b) Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted delivery. Polym Bull 68:1707–1720
Jiang J, Oberdörster G, Biswas P (2009) Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–89
Jiang L, Li X, Liu L, Zhang Q (2013) Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res Lett 8:66. https://doi.org/10.1186/1556-276X-8-66
Jin MX, Hu QH (2008) Characterization and application in bioadhesive drug delivery system of chitosan. Centr South Pharm 6:324–327
Kas HS (1997) Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 14:689–711
Kean T, Thanou M (2010) Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62:3–11
Kim JH, Kim YS, Park K, Lee S et al (2008) Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 127:41–49
Koo H, Min KH, Lee SC, Park JH, Park K et al (2013) Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. J Control Release 172:823–831
Kumari SDC, Tharani CB, Narayanan N, Kumar SC (2013) Formulation and characterization of methotrexate loaded sodium alginate chitosan nanoparticles. Ind J Res Pharm Biotechnol 1:915–921
Kuppens IE, Bosch TM, van Maanen MJ et al (2005) Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093). Cancer Chemother Pharmacol 55:72–78
Le TMP, Pham VP, Dang TML, La TH et al (2013) Preparation of curcumin-loaded pluronic F127/chitosan nanoparticles for cancer therapy. Adv Nat Sci Nanosci Nanotechnol 4:025001–025004
Lee SP, Tscharnuter W, Chu B (1972) Calibration of an optical self-beating spectrometer by polystyrene latex spheres, and confirmation of the Stokes-Einstein formula. J Polym Sci 10:2453–2459
Li F, Li J, Wen X, Zhoub S, Tong X et al (2009) Anti-tumor activity of paclitaxel-loaded chitosan nanoparticles: an in vitro study. Mater Sci Eng C 29:2392–2397
Li J, Ma FK, Dang QF, Liang XG, Chen XG (2014) Glucose-conjugated chitosan nanoparticles for targeted drug delivery and their specific interaction with tumor cells. Front Mater Sci 8:363–372
Luque-Alcaraz AG, Lizardi J, Goycoolea FM, Valdez MA et al (2012) Characterization and antiproliferative activity of nobiletin-loaded chitosan nanoparticles. J Nanomater. https://doi.org/10.1155/2012/265161
Mahapatro A, Singh DK (2011) Biodegradable nanoparticles are excellent vehicle for site directed in vivo delivery of drugs and vaccines. J Nanobiotechnol 9:55. https://doi.org/10.1186/1477-3155-9-55
Manikkam R, Pitchai D (2014) Catechin loaded chitosan nanoparticles as a novel drug delivery system for cancer – synthesis and in vitro and in vivo characterization. World J Pharm Pharm Sci 3:1553–1577
Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY et al (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70:399–421
Mazzarino L, Travelet C, Murillo SO et al (2012) Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface 370:58–66
Mehrotra A, Nagarwal RC, Kumar J (2011) Lomustine loaded chitosan nanoparticles: characterization and in vitro cytotoxicity on human lung cancer cell line L132. Chem Pharm Bull 59:315–320
Min KH, Park K, Kim YS, Bae SM, Lee S et al (2008) Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 127:208–218
Mitra S, Gaur U, Ghosh PC, Maitra AN (2001) Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74:317–323
Nogueira DR, Tavano L, Mitjans M, Perez L et al (2013) In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials 4:2758–2772
Ohya Y, Shiratani M, Kobayashi H, Ouchi T (1994) Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. J Macromol Sci Part A 31:629–642
Othayoth R, Santhosh Kumar K, Karthik V (2013) Development and characterization of chitosan-pluronic polymeric nanoparticles for the breast cancer treatment. Int J Mech Eng Robotics 1:71–79
Ozbas-Turan S, Aral C, Kabasakal L et al (2003) Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J Pharm Pharm Sci 6:27–32
Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H et al (2002) Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–147
Park K, Kim JH, Nam YS, Lee S et al (2007) Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release 122:305–314
Patel MP, Patel RR, Patel JK (2008) New drug delivery systems based on chitosan. Curr Drug Discovery Technol 5:333–341
Patel PN, Patel LJ, Patel JK (2011) Development and testing of novel temoxifen citrate loaded chitosan nanoparticles using ionic gelation method. Der Pharmacia Sinica 2:17–25
Prabaharan M, Mano J (2004) Chitosan based particles as controlled drug delivery systems. Drug Deliv 12:41–57
Prameela Rani A, Sivannarayana P, Abbulu K, Saikishore V (2014) Design and characterisation of Anastrazole loaded chitosan nanoparticles by ionotropic gelation method. Res J Pharm, Biol Chem Sci 5:2069–2078
Qi J, Yao P, He F, Yu C, Huang C (2010) Nanoparticles with dextran/chitosan shell and BSA/chitosan core-Doxorubicin loading and delivery. Int J Pharm 393:176–184
Qiu Y, Zhu J, Wang J, Gong R et al (2013) Self-assembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug. J Nanosci Nanotechnol 13:5935–5941
Rebucci M, Michiels C (2013) Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 85:1219–1226
Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2:8–21
Sahoo D, Parida UK, Rout N, Bindhani BK (2012) Preparation and characterization of chitosan nanoparticles for the controlled release of anticancer drug paclitaxel. Int J Pharm Bio Sci 11:1687–1698
Sakuma S, Hayashi M, Akashi M (2001) Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev 47:21–37
Salar RK, Kumar N (2016) Synthesis and characterization of vincristine loaded folic acid–chitosan conjugated nanoparticles. Resour-Efficient Technol 2(4):199–214
Salar RK, Sharma P, Kumar N (2015) Enhanced antibacterial activity of streptomycin against some human pathogens using green synthesized silver nanoparticles. Resour-Efficient Technol 1:106–115
Sangeetha S, Harish G, Samanta MK (2010) Chitosan-based nanospheres as drug delivery system for cytarabine. Int J Pharm Bio Sci 1:1–8
Saravanabhavan SS, Bose R, Skylab S, Dharmalingam S (2013) Fabrication of chitosan/TPP nanoparticles as a carrier towards the treatment of cancer. Int J Drug Deliv 5:35–42
Saremi S, Atyabi F, Akhlaghi SP et al (2011) Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Int J Nanomedicine 12:119–128
Saremi S, Dinarvand R, Kebriaeezadeh A et al (2013) Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies. Bio Med Res Int. https://doi.org/10.1155/2013/150478
Sevda S, McClureb SJ (2004) Potential applications of chitosan in veterinary medicine. Adv Drug Deliv Rev 56:1467–1480
Shakeri-Zadeh A, Khoei S, Khoee S, Sharifi AM, Shiran MB (2013) Targeted, monitored and controlled chemotherapy: a multimodal nanotechnology-based approach against cancer. ISRN Nanotech. https://doi.org/10.1155/2013/629510
Shi XW, Du YM, Yang JH (2005) Effect of degree of substitution and molecular weight of carboxymethyl chitosan nanoparticles on doxorubicin delivery. J Appl Polym Sci 100:4689–4696
Shi L, Tang C, Yin C (2012) Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials 33:7594–7604
Shi Z, Guo R, Li W, Zhang Y, Xue W et al (2014) Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin. J Mater Sci Mater Med 25:723–731
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA-Cancer J Clin 63:11–30
Snima KS, Jayakumar R, Unnikrishnan AG, Nair SV, Lakshmanan VK (2012) O-carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells. Carbohydr Polym 89:1003–1007
Song H, Su C, Cui W, Zhu B et al (2013) Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery. Biomed Res Int. https://doi.org/10.1155/2013/723158
Sun S, Murray C, Weller D, Folks L, Moser A (2000) Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 287:1989–1992
Sunil AA, Nadagouda NM, Tejraj M (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5–28
Talaei F, Azizi E, Dinarvand R, Atyabi F (2011) Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells. Int J Nanomed 6:1963–1975
Termsarasab U, Cho HJ, Kim DH, Chong S et al (2013) Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery. Int J Pharm 441:373–380
Trapani A, Denora N, Iacobellis G, Sitterberg J et al (2011) Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: A promising strategy for the administration of the anticancer drug to brain tumors. AAPS Pharm Sci Tech 12:1302–1311
Trickler WJ, Nagvekar AA, Dash AK (2008) A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS Pharm Sci Tech 9:486–493
Tsai HY, Chiu CC, Lin PC et al (2011) Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes. Macromol Biosci 11:680–688
Wang YS, Jiang Q, Li RS, Liu LL, Zhang QQ et al (2008) Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel. Nanotechnology 19:145101. https://doi.org/10.1088/0957-4484/19/14/145101
Wang JJ, Zeng ZW, Xiao RZ, Xie T et al (2011) Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 6:765–774
Wang W, Tong CY, Liu XY, Li T et al (2015) Preparation and functional characterization of tumor-targeted folic acid-chitosan conjugated nanoparticles loaded with mitoxantrone. J Cent South Univ 22:3311–3317
Xu XY, Zhou JP, Li L et al (2008) Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice. Acta Pharm Sin 43:743–748
Xu Y, Wang L, Li YK, Wang CQ (2014) Oxidation and pH responsive nanoparticles based on ferrocene-modified chitosan oligosaccharide for 5-fluorouracil delivery. Carbohydr Polym 114:27–35
Yang SJ, Lin CF, Kuo ML, Tan CT (2013) Photodynamic detection of oral cancers with high-performance chitosan-based nanoparticles. Biomacromolecules 14:3183–3191
Zimbone M, Calcagno L, Messina G, Baeri P, Compagnini G (2011) Dynamic light scattering and UV-vis spectroscopy of gold nanoparticles solution. Mater Lett 65:2906–2909
Zu Y, Zhao Q, Zhao X, Zu S, Meng L (2011) Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method. Int J Nanomedicine 6:3429–3441
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Salar, R.K., Kumar, N. (2018). Chitosan Nanoparticles as Carrier for Anticancer Drugs: An Overview. In: Gahlawat, S., Duhan, J., Salar, R., Siwach, P., Kumar, S., Kaur, P. (eds) Advances in Animal Biotechnology and its Applications. Springer, Singapore. https://doi.org/10.1007/978-981-10-4702-2_8
Download citation
DOI: https://doi.org/10.1007/978-981-10-4702-2_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4701-5
Online ISBN: 978-981-10-4702-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)